Smruthi Organics Limited Stock

Equities

540686

INE172E01011

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:53 2024-04-30 EDT 5-day change 1st Jan Change
157.6 INR +2.14% Intraday chart for Smruthi Organics Limited -0.06% -9.16%

Financials

Sales 2022 1.33B 15.98M 22M Sales 2023 1.41B 16.9M 23.26M Capitalization 1.47B 17.63M 24.26M
Net income 2022 104M 1.25M 1.72M Net income 2023 41M 491K 676K EV / Sales 2022 1.94 x
Net Debt 2022 25.25M 303K 416K Net Debt 2023 39.48M 473K 651K EV / Sales 2023 1.07 x
P/E ratio 2022
24.7 x
P/E ratio 2023
35.6 x
Employees 308
Yield 2022
1.34%
Yield 2023
1.56%
Free-Float 34.13%
More Fundamentals * Assessed data
Dynamic Chart
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Smruthi Organics Limited Approves Dividend for the Year Ended 31 March 2023 CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Smruthi Organics Limited Proposes Dividend for the Year Ended 31St March, 2023 CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Smruthi Organics Limited Announces Dividend for the Fiscal Year 2022-2023 CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Smruthi Organics Limited Approves the Dividend for the Year Ended March 31, 2022 CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Smruthi Organics Limited Recommends Dividend CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Smruthi Organics Limited Approves Board Changes CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
More news
1 day+2.14%
1 week-0.06%
Current month+7.87%
1 month+7.87%
3 months-14.93%
6 months-10.33%
Current year-9.16%
More quotes
1 week
151.80
Extreme 151.8
162.30
1 month
145.00
Extreme 145
162.30
Current year
142.10
Extreme 142.1
218.80
1 year
117.00
Extreme 117
218.80
3 years
110.95
Extreme 110.95
419.35
5 years
21.70
Extreme 21.7
419.35
10 years
15.07
Extreme 15.0667
419.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 89-07-10
Chief Executive Officer 40 09-04-05
Compliance Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 40 09-04-05
Chief Executive Officer 66 89-07-10
Director/Board Member 69 06-09-10
More insiders
Date Price Change Volume
24-04-30 157.6 +2.14% 2,466
24-04-29 154.3 +0.59% 5,593
24-04-26 153.4 -3.19% 8,031
24-04-25 158.4 +0.03% 6,700
24-04-24 158.4 +0.25% 1,303

Delayed Quote Bombay S.E., April 30, 2024 at 06:00 am

More quotes
Smruthi Organics Limited is an India-based active pharmaceutical ingredients (API) manufacturer serving pharmaceutical companies. The Company’s segments include Bulk Drugs and Drugs Intermediates and Formulation. It manufactures API products in the anti-diabetic, anti-hypertension and anti-infectives therapeutic categories. Its products include Amlodipine Besilate, Losartan Potassium, Telmisartan, Metformin HCL, S-Amlodipine Besilate, S-Amlodipine Malelate, Valsartan, Vildagliptin, Teneligliptin, Ciprofloxacin HCL, Diloxanide Furoate, Norfloxacin, Pefloxacin Mesylate, Ticagrelor, and others. It caters to both the Indian domestic as well as the rest of the world (ROW) markets, with clients spanning Asia, the Americas, and Africa. The Company has two manufacturing facilities in Solapur, India. The API facility is spread across 22-acre land.
More about the company
  1. Stock Market
  2. Equities
  3. 540686 Stock